New User? Sign Up | Sign In

Sec Form 4 Filing - Hagerman Philip R @ Diplomat Pharmacy Inc. - 2018-09-11

  1. About Form 4 Filing: Every director, officer or owner of more than ten percent of a class of equity securities registered under Section 12 of the '34 Act must file with the U.S. Securities and Exchange Commission (SEC) a statement of ownership regarding such security. The initial filing is on Form 3 and changes are reported on Form 4. The Annual Statement of beneficial ownership of securities is on Form 5. The forms contain information on the reporting person's relationship to the company and on purchases and sales of such equity securities.
  2. Form 4 is stored in SEC's EDGAR database. EDGAR is Electronic Data Gathering, Analysis and Retrieval System. It is a registered trademark of the SEC.

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Email a friend >>...

SPAC List: List of Special Purpose Acquisition Companies


The following is an SEC EDGAR document rendered as filed.
Here is the list of insider trading transaction codes.

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person *
Hagerman Philip R
2. Issuer Name and Ticker or Trading Symbol
Diplomat Pharmacy, Inc. [ DPLO]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
4100 S. SAGINAW STREET
3. Date of Earliest Transaction (MM/DD/YY)
09/11/2018
(Street)
FLINT, MI48507
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 1,330,099 I Philip R. Hagerman Revocable Trust ( 1 )
Common Stock 3,391,609 I 2007 Hagerman Family Trust GST ( 2 )
Common Stock 09/11/2018 S 57,500 D $ 19.2055 ( 3 ) 3,842,591 I The JH GST Trust ( 1 )
Common Stock 09/12/2018 S 109,845 D $ 19.1075 ( 4 ) 3,732,746 I The JH GST Trust ( 1 )
Common Stock 09/13/2018 S 42,022 D $ 18.7804 ( 5 ) 3,690,724 I The JH GST Trust ( 1 )
Common Stock 1,475,876 I 2013 Irrev. Exempt Trust for Daughter ( 2 )
Common Stock 1,475,876 I 2013 Irrev. Exempt Trust for Son ( 2 )
Common Stock 1,075,293 I 2013 Irrev. Exempt Trust for Daughter ( 1 )
Common Stock 1,311,292 I 2013 Irrev. Exempt Trust for Daughter ( 1 )
Common Stock 313,337 I 2014 Irrev. Exempt Trust for Son ( 2 )
Common Stock 313,337 I 2014 Irrev. Exempt Trust for Daughter ( 2 )
Common Stock 313,337 I 2014 Irrev. Exempt Trust For Daughter ( 1 )
Common Stock 313,337 I 2014 Irrev. Exempt Trust for Daughter ( 1 )
Common Stock 417,528 I Jocelyn Hagerman Living Trust ( 2 )
Common Stock 263,500 I JH Marital Trust ( 1 )
Common Stock 272,000 I PH Marital Trust ( 2 )
Common Stock 394,910 I Irrevocable Trust for Son
Common Stock 394,910 I Irrevocable Trust for Daughter
Common Stock 367,256 I Irrevocable Non-Exempt Trust for Son
Common Stock 367,256 I Irrevocable Non-Exempt Trust for Daughter
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Hagerman Philip R
4100 S. SAGINAW STREET
FLINT, MI48507
X X
Signatures
/s/ Christina Flint, by Power of Attorney 09/13/2018
** Signature of Reporting Person Date
Explanation of Responses:
( 1 )These shares are indirectly owned by Mr. Hagerman as the trustee of the Philip R. Hagerman Revocable Trust, The JH GST Trust, the 2013 Irrevocable Exempt Trusts and 2014 Irrevocable Exempt Trusts for two daughters, and the JH Marital Trust.
( 2 )Jocelyn Hagerman is Mr. Hagerman's wife. These shares are indirectly owned by her as a trustee of the 2007 Hagerman Family GST Trust, the 2013 Irrevocable Exempt Trusts and 2014 Irrevocable Exempt Trusts for a son and daughter, the Jocelyn Hagerman Living Trust, and the PH Marital Trust.
( 3 )The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $18.72 to $19.64. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
( 4 )The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $18.76 to $19.38. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
( 5 )The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $18.61 to $19.30. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.